Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSeeing Machines Regulatory News (SEE)

Share Price Information for Seeing Machines (SEE)

Share Price is delayed by 15 minutes
Get Live Data
4.40    0.00 (0.00%)
Bid:
4.40
Ask:
4.525
Spread: 0.125 (2.841%)
Market Cap: £211.18m
SEE Live PriceLast checked at - London Stock Exchange

Intraday Seeing Machines Share Chart

AGM Statement

30 Nov 2006 08:27

Seeing Machines Limited30 November 2006 30 November 2006 Seeing Machines Limited ("Seeing Machines" or the "Company") Annual General Meeting Seeing Machines (AIM: SEE), a leading developer of advanced computer basedimaging software systems, announces that at its Annual General Meeting heldtoday in Canberra all proposed resolutions regarding the re-election ofdirectors were duly passed. Full copies of the addresses made by the Chairman and the CEO are available onthe Company's website, www.seeingmachines.com. Enquiries:Seeing Machines Limited Insinger de Beaufort Parkgreen CommunicationsNick Cerneaz, CEO Simon Fox Justine Howarth / Victoria Thomas+61 (0) 2 6125 6501 +44 (0) 20 7190 7018 +44 (0) 20 7493 3713www.seeingmachines.com Notes to Editors: Specifically highlighted in the Address to the Annual General Meeting of SeeingMachines made by the Company's Chairman, Fulton Muir were the following keypoints: • The company achieved its best ever results for the year ended 30 June 2006: • Revenue up 70% to A$2.4 million • After-tax loss of A$135,077 down 89% on the previous year's loss of $1.228 million • Cash reserves of A$2.4 million up 263% on the previous year o The sale of the faceLAB product has been largely responsible for therevenue growth in the past year. It continues to be sold to many prestigiousinstitutions involved in R&D including motor vehicle manufacturers, universitiesand defence organisations. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
30th Aug 200611:46 amRNSClinical Study Results
14th Aug 200610:57 amRNSGrant Approval
6th Jul 20069:12 amRNSDirector/PDMR Shareholding
29th Jun 20069:37 amRNSEmployee Share Option Scheme
27th Jun 200610:11 amRNSGrant of US Patent
5th Jun 200610:14 amRNSHolding(s) in Company
10th May 20069:27 amRNSHolding(s) in Company
13th Apr 20063:25 pmRNSDirector/PDMR Shareholding
13th Apr 200612:47 pmRNSNew faceLAB Camera Product
10th Apr 20069:19 amRNSMajor Industry Awards Win
15th Mar 20067:01 amRNSInterim Results
3rd Mar 20069:42 amRNSAGM Statement-Amendment
28th Feb 20069:15 amRNSAGM Statement
8th Feb 20069:25 amRNSHolding(s) in Company
31st Jan 20069:30 amRNSHolding(s) in Company
25th Jan 20069:24 amRNSHolding(s) in Company
10th Jan 20069:18 amRNS1st Glaucoma Trial Completion
20th Dec 20053:46 pmRNSIssue of Equity
6th Dec 20059:41 amRNSHolding(s) in Company
1st Dec 20058:53 amRNSAdmission to AIM-Replacement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.